MA47605A - Procédés de purification d'arn messager - Google Patents

Procédés de purification d'arn messager

Info

Publication number
MA47605A
MA47605A MA047605A MA47605A MA47605A MA 47605 A MA47605 A MA 47605A MA 047605 A MA047605 A MA 047605A MA 47605 A MA47605 A MA 47605A MA 47605 A MA47605 A MA 47605A
Authority
MA
Morocco
Prior art keywords
messenger rna
purification processes
rna purification
processes
messenger
Prior art date
Application number
MA047605A
Other languages
English (en)
Inventor
Jonathan Abysalh
Daniel Crawford
Frank Derosa
Anusha Dias
Michael Heartlein
Shrirang Karve
Original Assignee
Translate Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translate Bio Inc filed Critical Translate Bio Inc
Publication of MA47605A publication Critical patent/MA47605A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502753Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/028Modular arrangements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/16Reagents, handling or storing thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0681Filter
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0409Moving fluids with specific forces or mechanical means specific forces centrifugal forces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/113Denaturating agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/30Characterised by physical treatment
    • C12Q2523/308Adsorption or desorption
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y201/00Transferases transferring one-carbon groups (2.1)
    • C12Y201/03Carboxy- and carbamoyltransferases (2.1.3)
    • C12Y201/03003Ornithine carbamoyltransferase (2.1.3.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
MA047605A 2017-02-27 2018-02-27 Procédés de purification d'arn messager MA47605A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762463998P 2017-02-27 2017-02-27

Publications (1)

Publication Number Publication Date
MA47605A true MA47605A (fr) 2020-01-01

Family

ID=61628474

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047605A MA47605A (fr) 2017-02-27 2018-02-27 Procédés de purification d'arn messager

Country Status (11)

Country Link
US (2) US10808241B2 (fr)
EP (2) EP3971291A1 (fr)
AU (1) AU2018224843A1 (fr)
CA (1) CA3054321A1 (fr)
CY (1) CY1124735T1 (fr)
DK (1) DK3585891T3 (fr)
ES (1) ES2899323T3 (fr)
HU (1) HUE059025T2 (fr)
IL (1) IL268857B1 (fr)
MA (1) MA47605A (fr)
WO (1) WO2018157133A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012267578B2 (en) 2011-06-08 2017-04-20 Translate Bio, Inc. Cleavable lipids
EP2970955B1 (fr) 2013-03-14 2018-11-14 Translate Bio, Inc. Procédés de purification d'arn messager
MA47605A (fr) * 2017-02-27 2020-01-01 Translate Bio Inc Procédés de purification d'arn messager
EP3714048A1 (fr) 2017-11-22 2020-09-30 Modernatx, Inc. Polynucléotides codant pour l'ornithine transcarbamylase pour le traitement de troubles du cycle de l'urée
CA3097912A1 (fr) * 2018-05-15 2019-11-21 Translate Bio, Inc. Administration sous-cutanee d'arn messager
CN112930396B (zh) 2018-08-24 2024-05-24 川斯勒佰尔公司 用于纯化信使rna的方法
US20210388338A1 (en) * 2018-11-08 2021-12-16 Translate Bio, Inc. Methods and Compositions for Messenger RNA Purification
CN113396219A (zh) 2019-02-11 2021-09-14 埃泽瑞斯公司 通过切向流过滤纯化mRNA
CN114127283A (zh) * 2019-05-15 2022-03-01 川斯勒佰尔公司 用于纯化信使rna的方法
CN115515559A (zh) 2019-12-20 2022-12-23 翻译生物公司 信使rna的直肠递送
WO2021127641A1 (fr) 2019-12-20 2021-06-24 Translate Bio, Inc. Procédé amélioré de préparation de nanoparticules lipidiques chargées d'arnm
WO2021163134A1 (fr) 2020-02-10 2021-08-19 Translate Bio, Inc. Procédés et compositions pour purification d'arn messager
WO2021173840A1 (fr) 2020-02-25 2021-09-02 Translate Bio, Inc. Procédés améliorés de préparation de nanoparticules lipidiques chargées d'arnm
CA3177940A1 (fr) 2020-05-07 2021-11-11 Anusha DIAS Sequences nucleotidiques optimisees codant pour des antigenes du sras-cov-2
US20230190954A1 (en) 2020-05-07 2023-06-22 Translate Bio, Inc. Composition and methods for treatment of primary ciliary dyskinesia
JP2023526284A (ja) 2020-05-15 2023-06-21 トランスレイト バイオ, インコーポレイテッド mRNA送達のための脂質ナノ粒子製剤
CA3197638A1 (fr) * 2020-10-01 2022-04-07 Translate Bio, Inc. Procedes de purification d'arn messager
CA3194863A1 (fr) 2020-10-06 2022-04-14 Shrirang KARVE Procede ameliore et formulation de nanoparticules lipidiques
US20220133631A1 (en) 2020-10-12 2022-05-05 Translate Bio, Inc. Process of preparing ice-based lipid nanoparticles
KR20230087536A (ko) 2020-10-12 2023-06-16 트랜슬레이트 바이오 인코포레이티드 Mrna-로딩된 지질 나노입자를 제조하는 개선된 프로세스
WO2022204549A1 (fr) 2021-03-25 2022-09-29 Translate Bio, Inc. Séquences nucléotidiques optimisées codant pour le domaine extracellulaire de la protéine ace2 humaine ou une portion de celle-ci
JP2024515668A (ja) 2021-04-19 2024-04-10 トランスレイト バイオ, インコーポレイテッド Mrnaの送達のための改善された組成物
WO2023278754A1 (fr) 2021-07-01 2023-01-05 Translate Bio, Inc. Compositions de livraison d'arnm
WO2023086893A1 (fr) 2021-11-10 2023-05-19 Translate Bio, Inc. Composition et méthodes de traitement de la dyskinésie ciliaire primitive
WO2024083345A1 (fr) 2022-10-21 2024-04-25 BioNTech SE Procédés et utilisations associés à des compositions liquides
WO2024112652A1 (fr) 2022-11-21 2024-05-30 Translate Bio, Inc. Compositions de formulations de poudre sèche d'arn messager et leurs procédés d'utilisation
WO2024126809A1 (fr) 2022-12-15 2024-06-20 Sanofi Arnm codant pour une particule de type virus de la grippe
WO2024133515A1 (fr) 2022-12-20 2024-06-27 Sanofi Vaccin contre l'arnm de rhinovirus
WO2024133884A2 (fr) 2022-12-23 2024-06-27 Sanofi Queue optimisée d'arn messager

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5139667A (en) 1988-12-20 1992-08-18 Sparkler Filters, Inc. Nutsche process filter drive unit
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5544425A (en) 1995-05-17 1996-08-13 Mallinckrodt Medical, Inc. Aggressive convective drying in a nutsche type filter/dryer
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
JP3930616B2 (ja) 1997-08-25 2007-06-13 住友化学株式会社 2−アミノ−6置換プリンの精製方法
DE19917558C2 (de) 1999-04-19 2003-05-08 Joachim Schwindling Filtrationsapparat
EP1390414B1 (fr) 2001-05-14 2006-08-30 Polytag Technology SA Procede de separation de composes d'amides (meth)acryliques n-substitues oligomeres a precipitation thermique reversible, et de leurs conjugues
DE10131107A1 (de) 2001-06-27 2003-01-09 Mann & Hummel Filter Filtervorrichtung bzw. schwenkbares Filtermedium für diese Filtervorrichtung
JP2004167345A (ja) 2002-11-19 2004-06-17 Sumitomo Chem Co Ltd 固体粒子の洗浄方法
US7267950B2 (en) 2003-05-01 2007-09-11 Veridex, Lcc Rapid extraction of RNA from cells and tissues
US7709240B2 (en) 2004-04-28 2010-05-04 Amano Enzyme Inc. AMP deaminase originating streptomyces and utilization thereof
US7473511B2 (en) * 2004-12-15 2009-01-06 Fuji Xerox Co., Ltd. Particle dispersion for electrostatic image-developing toners, electrostatic image-developing toner, and method for producing the same
US7494794B2 (en) 2006-03-31 2009-02-24 Toyo Boseki Kabushiki Kaisha Glucose dehydrogenase
WO2008078646A1 (fr) 2006-12-22 2008-07-03 Ajinomoto Co., Inc. Procédé de séparation de cristaux d'acide aminé ou d'acide nucléique
US20090065435A1 (en) 2007-09-10 2009-03-12 Powell Intellectual Property Holdings, Llc Modified Biogenic Silica and Method for Purifying a Liquid
US20090148384A1 (en) 2007-12-10 2009-06-11 Fischer Katrin Functionalized, solid polymer nanoparticles comprising epothilones
CN102065870B (zh) 2008-04-16 2014-11-19 比奥根艾迪克Ma公司 使用聚亚烷基二醇和过渡金属分离生物大分子的方法
JP6087504B2 (ja) 2008-11-07 2017-03-01 マサチューセッツ インスティテュート オブ テクノロジー アミノアルコールリピドイドおよびその使用
US20130059008A1 (en) 2009-01-23 2013-03-07 Jeffrey L. Atkinson Drying methods for tuning microparticle properties
WO2011031566A1 (fr) 2009-08-27 2011-03-17 Newlight Technologies, Llc Procédé de fabrication de polyhydroxyalcanoates
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
NZ700688A (en) 2009-12-01 2016-02-26 Shire Human Genetic Therapies Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
US8853377B2 (en) 2010-11-30 2014-10-07 Shire Human Genetic Therapies, Inc. mRNA for use in treatment of human genetic diseases
AU2012267578B2 (en) 2011-06-08 2017-04-20 Translate Bio, Inc. Cleavable lipids
JP6184945B2 (ja) 2011-06-08 2017-08-23 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド mRNA送達のための脂質ナノ粒子組成物および方法
JP6072788B2 (ja) * 2011-07-25 2017-02-01 サンガモ バイオサイエンシーズ, インコーポレイテッド 嚢胞性線維症膜コンダクタンス制御因子(cftr)遺伝子を改変するための方法および組成物
AU2012328570B2 (en) 2011-10-27 2017-08-31 Massachusetts Institute Of Technology Amino acid derivatives functionalized on the n-terminus capable of forming drug encapsulating microspheres and uses thereof
BR112014024131A2 (pt) 2012-03-29 2017-07-25 Shire Human Genetic Therapies lipídios catiônicos ionizáveis
US9877919B2 (en) 2012-03-29 2018-01-30 Translate Bio, Inc. Lipid-derived neutral nanoparticles
EP3536787A1 (fr) 2012-06-08 2019-09-11 Translate Bio, Inc. Polynucléotides résistant aux nucléases et leurs utilisations
EA201492055A1 (ru) 2012-06-08 2015-11-30 Шир Хьюман Дженетик Терапис, Инк. ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
EP2929035A1 (fr) 2012-12-07 2015-10-14 Shire Human Genetic Therapies, Inc. Nanoparticules lipidiques pour administration de marn
EA037922B1 (ru) 2013-03-14 2021-06-07 Шир Хьюман Дженетик Терапис, Инк. мРНК CFTR И КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ МУКОВИСЦИДОЗА У МЛЕКОПИТАЮЩЕГО
EP2970955B1 (fr) 2013-03-14 2018-11-14 Translate Bio, Inc. Procédés de purification d'arn messager
ES2647832T3 (es) 2013-03-14 2017-12-26 Translate Bio, Inc. Ácidos ribonucleicos con nucleótidos modificados con 4-tio y procedimientos relacionados
HUE055044T2 (hu) 2013-03-14 2021-10-28 Translate Bio Inc MRNS-kódolt ellenanyagok bejuttatására szolgáló eljárások és készítmények
CN105209633A (zh) 2013-03-14 2015-12-30 夏尔人类遗传性治疗公司 信使rna加帽效率的定量评估
ES2680595T3 (es) 2013-03-14 2018-09-10 Translate Bio, Inc. Evaluación cuantitativa para eficacia de ARN mensajero para tapar
EP3431592A1 (fr) 2013-03-14 2019-01-23 Translate Bio, Inc. Compositions thérapeutiques d'arnm et utilisation dans le traitement de maladies et de troubles
CA2906281A1 (fr) 2013-03-15 2014-09-18 Glaxosmithkline Biologicals Sa Procedes de purification de l'arn
ES2954366T3 (es) 2013-10-22 2023-11-21 Translate Bio Inc Terapia de ácido ribonucleico mensajero para la deficiencia de argininosuccinato sintetasa
EP3060257B1 (fr) 2013-10-22 2021-02-24 Translate Bio, Inc. Compositions des lipides pour l'administation arnm
CA2928186A1 (fr) 2013-10-22 2015-04-30 Shire Human Genetic Therapies, Inc. Therapie a l'arnm pour la phenylcetonurie
EP4036241A1 (fr) 2013-10-22 2022-08-03 Translate Bio, Inc. Administration de l'arnm dans le snc et leurs utilisation
TR201900649T4 (tr) 2014-03-24 2019-02-21 Translate Bio Inc Oküler hastalıkların tedavisi için mrna tedavisi.
ES2750661T3 (es) * 2014-04-25 2020-03-26 Translate Bio Inc Métodos para la purificación de ARN mensajero
JP6557722B2 (ja) 2014-05-30 2019-08-07 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 核酸の送達のための生分解性脂質
ES2964588T3 (es) 2014-06-24 2024-04-08 Translate Bio Inc Composiciones enriquecidas estereoquímicamente para la administración de ácidos nucleicos
CN114146063A (zh) 2014-07-02 2022-03-08 川斯勒佰尔公司 信使rna的包封
WO2016149508A1 (fr) 2015-03-19 2016-09-22 Shire Human Genetic Therapies, Inc. Thérapie d'arnm pour maladie de pompe
KR101693166B1 (ko) 2016-07-12 2017-01-06 정수영 분말 액체 혼합물용 누체 여과 건조 장치
MA47605A (fr) * 2017-02-27 2020-01-01 Translate Bio Inc Procédés de purification d'arn messager
AU2019258679A1 (en) 2018-04-25 2020-10-15 Ethris Gmbh Cryoprotective agents for particulate formulations

Also Published As

Publication number Publication date
US20210123041A1 (en) 2021-04-29
CA3054321A1 (fr) 2018-08-30
ES2899323T3 (es) 2022-03-10
EP3585891A1 (fr) 2020-01-01
HUE059025T2 (hu) 2022-10-28
AU2018224843A1 (en) 2019-09-19
US10808241B2 (en) 2020-10-20
EP3971291A1 (fr) 2022-03-23
WO2018157133A1 (fr) 2018-08-30
US20180251755A1 (en) 2018-09-06
IL268857A (en) 2019-10-31
EP3585891B1 (fr) 2021-10-27
IL268857B1 (en) 2024-05-01
DK3585891T3 (da) 2021-11-22
US11976272B2 (en) 2024-05-07
CY1124735T1 (el) 2022-07-22

Similar Documents

Publication Publication Date Title
MA47606A (fr) Procédés de purification d'arn messager
MA47605A (fr) Procédés de purification d'arn messager
MA44732A (fr) Procédés de production d'arn simple brin
MA49913A (fr) Variants d'arn polymérase
MA49421A (fr) Formulations d'arn
MA47607A (fr) Synthèse à grande échelle d'arn messager
EP3727636A4 (fr) Système de purification d'air
EP3464313A4 (fr) Nucléotides modifiés 5 '-cyclo-phosphonate
IL281804A (en) Protein purification methods
FR3036037B1 (fr) Harnais d'encordement perfectionne
IL261040B (en) Protein purification
EP3412623A4 (fr) Procédé de purification
EP3387003A4 (fr) Protéine d'immunité de la colicine bactérienne, système de purification de protéines
GB201711481D0 (en) Protein purification
MA41842A (fr) Nouveaux procédés de sélection d'épitope
MA52417A (fr) Procédés de modification de composition corporelle
EP3438426A4 (fr) Système de purification d'échappement
MA47014A (fr) Procédé de purification d'antibiotiques lipopeptidiques
EP3488087A4 (fr) Système d'échappement à l'échelle du timbre
EP3594183A4 (fr) Système de purification d'eau
EP3406623A4 (fr) Procédé de purification de protéine
EP3702545A4 (fr) Système de purification
EP3392200A4 (fr) Système de purification d'eau
FR3036295B1 (fr) Accessoire d'aeration de vin
GB2586524B (en) Earbud clip